Disease-modifying therapies reduce relapse rates in multiple sclerosis. However, they often only incompletely address the aspects of oxidative stress and long-term neurodegeneration. Spirulina, a microalgae, is known for its strong antioxidant and anti-inflammatory properties due to its richness in phycocyanin, phenolic compounds and omega-3 fatty acids.
Autoren
- Dr. Ulf Blanke
Publikation
- InFo NEUROLOGIE & PSYCHIATRIE
Related Topics
You May Also Like
- Multiple sclerosis
Spirulina as adjuvant therapy? Reduction of cytokines and inflammation
- IBD and SARS-CoV-2
Vulnerable at the mercy of others
- Case Report
53-year-old female patient with palmoplantar keratoderma
- Diagnostics of respiratory viral infections
What is tested when and on whom?
- Incontinence
Fecal incontinence from the perspective of gastroenterology
- HER2-positive breast cancer
ENPP1 as a biomarker for poor prognosis and early detection of brain metastases
- Update 2025
Hypercholesterolemia
- GPP: from molecular principles to targeted therapy